In vitro Immunomodulating Effects of PALMIWON

팔미원의 in vitro 면역조절 작용

  • Lee, Ihn-Soon (College of Pharmacy, Catholic University of Taegu-Hyoseung) ;
  • Rhee, In-Ja (Department of Life Scienc, Pohang University of Science and Technology)
  • 이인순 (포항공과대학교 생명과학과) ;
  • 이인자 (대구효성 가톨릭대학교 약학대학)
  • Published : 1996.12.01

Abstract

PALMIWON is composed of 8 oriental herbs which has been known to show some pharmacological effects in kidney, blood vessels and immune systems, and used for the treatment of kid ney disease, hypertension, nervous disease and diabetic mellitus in the Orient for a long time. Based on our previous report that PALMIWON showed different effects on immune cells and ${\beta}$-cells, the immunoreactivity of ICSA (Islet Cell Surface Antibody) with ${\beta}$-cell (RINm5F) and the cell proliferation and function of interleukin-1${\beta}$ damaged ${\beta}$-cells in the presence of PALMIWON were examined. It was observed that PALMIWON significantly inhibited the immunoreactivity of ICSA with ${\beta}$-cell, and markedly increased cell proliferation and insulin release of interleukin-1${\beta}$ damaged ${\beta}$-cells.

Keywords

References

  1. 한방의 약리해설 박영순
  2. 동의 처방대전 1 동의 과학원
  3. 생약학 韓大錫
  4. 효성여자대학교 응용과학연구논문집 v.3 팔미원이 Streptozotocin으로 유발한 실험적 당뇨백서에 미치는 영향 이인자;신정연
  5. 효성여자대학교 응용과학 연구논문집 v.2 팔미원과 Gliclazide 병용투여가 실험적 당뇨백서에 미치는 영향 이인자;박성희
  6. 藥學雜誌 v.101 生藥の 生物活性 成分に 關する 硏究 Streptozotocin による 病態 モテルを用 ぃた 山茱萸抗糖尿病活性 成分 の檢討 山原條一;壬生寬之;藤村一
  7. 생약학회지 v.12 팔미원이 신성고혈압에 미치는 영향 노영수;홍남두;김수옥;김남재
  8. 경희한의대 논문집 v.5 기아백서 혈청중 전해질 및 대사기질의 변동에 대한 팔미원의 효과 신민규;김완희
  9. Islet cell surface antibodies and diabetes mellitus in immunology of diabetes Lernmark, A.;Freeman, Z. F.;Kanatsuna, T. I.;Patzelt, C.;Rubenstein, A. H.;Steiner, D. F.;Irvine, W. J.(ed.)
  10. Diabetes v.34 Cytotoxic islet cell surface antibodies(ICSA) in patients with type Ⅰdiabetes and their first-degree relatives Toguchi, Y.;Ginsberg-Fellner, F.;Rubinstein, P.
  11. Diabetes v.39 Studies on autoimmunity for initiation of β-cell destruction Amano K.;Yoon J. W.
  12. J. Clin. Invest. v.75 Passive transfer of diabetes from BB/W to Wistar-Furth rats Koevary, S. B.;Williams, D. E.;Williams, R. M.;Chick, W. L.
  13. Diabetol. v.31 Prevention of lymphocytic throiditis and insulitis in diabetes-prone BB rats by depletion of macrophage Lee, K. U.;Pak, C. Y.;Amano, K.;Yoon, J. W.
  14. Immunoassays In Immunochemistry in Practice(2nd.) A. Johnslone;R. Thorpe
  15. Methods in Diabetes Research v.1 Cytotoxic mechanisms in insulin-dependent Diabetes Mellitus M. A. Ghalambor;H. G. Rittenhouse;S. A. Schwartz;S. M. Pek;D. AR;D. L. Oxender;J. Larner(ed.);S. L. Pohl.(ed.)
  16. Methods in Diabetes Research v.1 Pancreatic Monolayer cultures-Preparation of purified Islets cell cultures and Assessment of β cell replication A. Rabinovitch;Joseph Larner(ed.);S. L. Pohl(ed.)
  17. Amer. J. Physiol. v.256 Interleukin-1 is a potent stimulator of islet insulin secretion and phosphoinositide hydrolysis Zawalich, W. S.;Zawalich, K. C.
  18. Diabetes v.41 Does nitric oxide mediate autoimmune destruction of β-cells Corbett, J. A.;Mcdaniel, M. L.
  19. Duabetol. v.34 An interleukin-1 receptor antagonist protein protects insulin-producing β-cells against suppressive effects of interleukin-1β Eizirik, D. I.;Tracey, D. E.;Bendtzen, K.;Sandler, S.
  20. 약학회지 v.39 췌장소도세포와 면역세포에 미치는 팔미원의 영향 이인순;이인자